Who invested in Stelexis Therapeutics?
Stelexis Therapeutics's investors include LD Capital and Deerfield.

United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Stelexis Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$43Mraised across 1 round since 2019, from 1 source
Stelexis Therapeutics's investors include LD Capital and Deerfield.
Stelexis Therapeutics has raised $43M across 1 round since 2019.
Stelexis Therapeutics's most recent round was a Series A of $43M in Jan 2019.
Its most recent round, $43M in Jan 2019, is also its largest on record.
Stelexis Therapeutics's first round on record, in Jan 2019, was backed by LD Capital and Deerfield.
Stelexis Therapeutics's latest named round is a Series A, in Jan 2019.
Stelexis Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.